GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hill-Rom Holdings Inc (NYSE:HRC) » Definitions » 5-Year Yield-on-Cost %

Hill-Rom Holdings (Hill-Rom Holdings) 5-Year Yield-on-Cost % : 0.84 (As of May. 05, 2024)


View and export this data going back to 1989. Start your Free Trial

What is Hill-Rom Holdings 5-Year Yield-on-Cost %?

Hill-Rom Holdings's yield on cost for the quarter that ended in Sep. 2021 was 0.84.


The historical rank and industry rank for Hill-Rom Holdings's 5-Year Yield-on-Cost % or its related term are showing as below:

HRC' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.84   Med: 1.57   Max: 2.58
Current: 0.84


During the past 13 years, Hill-Rom Holdings's highest Yield on Cost was 2.58. The lowest was 0.84. And the median was 1.57.


HRC's 5-Year Yield-on-Cost % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.21 vs HRC: 0.84

Competitive Comparison of Hill-Rom Holdings's 5-Year Yield-on-Cost %

For the Medical Instruments & Supplies subindustry, Hill-Rom Holdings's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hill-Rom Holdings's 5-Year Yield-on-Cost % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hill-Rom Holdings's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Hill-Rom Holdings's 5-Year Yield-on-Cost % falls into.



Hill-Rom Holdings 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Hill-Rom Holdings is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Hill-Rom Holdings  (NYSE:HRC) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Hill-Rom Holdings 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Hill-Rom Holdings's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hill-Rom Holdings (Hill-Rom Holdings) Business Description

Traded in Other Exchanges
N/A
Address
130 East Randolph Street, Suite 1000, Chicago, IL, USA, 60601
Hill-Rom Holdings Inc is a global provider of hospital equipment and medical supplies, including hospital beds for high- and low-acuity settings. Hill-Rom reports financial data across three operating segments: patient support systems (50% of fiscal 2018 sales), front-line care (34%), and surgical solutions (16%). The firm has significant operations internationally, with roughly 30% of revenue derived from international sources and the remaining 70% from its U.S. business.
Executives
Mary Kay Ladone officer: SVP, Corp. Dev., Strat. & IR 130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601
Deborah Rasin officer: SVP, Chief Legal Officer TWO PRUDENTIAL PLAZA, SUITE 4100, CHICAGO IL 60601
Paul Sherwood Johnson officer: SVP & Pres. - PSS Acute Care TWO PRUDENTIAL PLAZA 180 NORTH STETSON AVENUE, SUITE 4100 CHICAGO IL 60601
Andreas G Frank officer: SVP, Pres. Front Line Care C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Richard M Wagner officer: Corporate Controller 221 WEST PHILADELPHIA STREET, SUITE 60W, YORK PA 17401-2991
Amy M. Dodrill officer: President - Surgical Solutions 130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601
Gary Lee Ellis director THE TORO COMPANY, 8111 LYNDALE AVENUE SOUTH, BLOOMINGTON MN 55420
Mary Garrett director ETHAN ALLEN DRIVE, DANBURY CT 06811
Gregory J. Moore director 130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601
William Kucheman director C/O DAN DUGAN, FINANCIAL PERSPECTIVES, 3025 HARBOR LN., SUITE 200, PLYMOUTH MN 55447
James R Giertz director
Ronald A Malone director 3 HUNTINGTON QUADRANGLE, SUITE 200S, MELVILLE NY 11747
Felicia F Norwood director 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
William G Dempsey director C/O LANDAUER, INC., 2 SCIENCE ROAD, GLENWOOD IL 60425
Nancy M Schlichting director 200 WILMOT ROAD, DEERFIELD IL 60015